Don't sell the tobacco stock short. XXII has pat
Post# of 72440
Posted On: 11/29/2013 8:44:37 PM
Don't sell the tobacco stock short. XXII has patented (about 110 worldwide with 3 in CHINA) every gene in the tobacco leaf that controls nicotine and now can make ultra high nicotine leaf down to negligible nicotine leaf (no more nicotine than you would find in a bell pepper, tomato, or potato). Can also alter tar down but right now can't give a combined low tar/low nicotine cig. but that is being worked on now.
Could be that any VLN (very low nicotine) cigarette in the world will have to use this technology and a recent study showed that 90% of worldwide smokers would consider switching to a safer cigarette.
As a disclaimer, this is my biggest holding because if they are the least bit successful it should become a dividend cash cow down the line. I envision $500K/yr dividends within a 3-5 yr time frame but that is strictly an opinion and I slide quite a bit to the highly optimistic side.
Recently signed an agreement with 2nd largest cigarette company in the world (BAT - $3200+ per share) . If they only get 3% of worldwide market, that is $21B per year.
Just saying don't overlook just because it is tobacco. Many revenue streams from various forms of their product. Should also provide the best method to stop smoking (based on two completed clinical trials) available. Also, FDA currently paying to test XXII's VLN cigs. FDA has bought about 5MM per year for past couple of years to study and called XXII for a meeting prior to starting trial in June/July. Could be one day XXII has the ONLY Low Risk Cigarette authorized in the USA.
Could be that any VLN (very low nicotine) cigarette in the world will have to use this technology and a recent study showed that 90% of worldwide smokers would consider switching to a safer cigarette.
As a disclaimer, this is my biggest holding because if they are the least bit successful it should become a dividend cash cow down the line. I envision $500K/yr dividends within a 3-5 yr time frame but that is strictly an opinion and I slide quite a bit to the highly optimistic side.
Recently signed an agreement with 2nd largest cigarette company in the world (BAT - $3200+ per share) . If they only get 3% of worldwide market, that is $21B per year.
Just saying don't overlook just because it is tobacco. Many revenue streams from various forms of their product. Should also provide the best method to stop smoking (based on two completed clinical trials) available. Also, FDA currently paying to test XXII's VLN cigs. FDA has bought about 5MM per year for past couple of years to study and called XXII for a meeting prior to starting trial in June/July. Could be one day XXII has the ONLY Low Risk Cigarette authorized in the USA.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼